Converge Bio Raises $5.5M in Seed Funding to Advance Generative AI in Drug Discovery

Converge Bio has successfully raised $5.5 million in seed funding to advance its generative AI initiatives in drug discovery and development. The funding round, which was oversubscribed, aims to help biotech companies enhance their large language models (LLMs) for better understanding and application in the field of biology. Converge Bio's 'everything store' for biotech LLMs is designed to accelerate innovation in AI-powered neuroimaging and oncology solutions.